We have examined the dynamics of cAMP-response element-binding protein (CREB) binding to chromatin in live cells using fluorescence recovery after photobleaching (FRAP). CREB was found to bind to target sites with a residence time of 100 s, and exposure to a cAMP agonist had no effect on these kinetics. In addition to the basic region/leucine zipper (bZIP) domain, a glutamine-rich trans-activation domain in CREB called Q2 also appeared to be critical for promoter occupancy. Indeed, mutations in Q2 that reduced residence time by FRAP assay disrupted target gene activation via CREB in cells exposed to a cAMP agonist. Notably, insertion of the glutamine-rich B trans-activation domain of SP1 into a mutant CREB polypeptide lacking Q2 stabilized CREB occupancy and rescued target gene activation. These results suggest a novel mechanism by which the family of glutamine-rich activators promotes cellular gene expression.
We have examined the dynamics of cAMP-response element-binding protein (CREB) binding to chromatin in live cells using fluorescence recovery after photobleaching (FRAP). CREB was found to bind to target sites with a residence time of 100 s, and exposure to a cAMP agonist had no effect on these kinetics. In addition to the basic region/leucine zipper (bZIP) domain, a glutamine-rich trans-activation domain in CREB called Q2 also appeared to be critical for promoter occupancy. Indeed, mutations in Q2 that reduced residence time by FRAP assay disrupted target gene activation via CREB in cells exposed to a cAMP agonist. Notably, insertion of the glutamine-rich B trans-activation domain of SP1 into a mutant CREB polypeptide lacking Q2 stabilized CREB occupancy and rescued target gene activation. These results suggest a novel mechanism by which the family of glutamine-rich activators promotes cellular gene expression.
cAMP stimulates the expression of cellular genes via the protein kinase A-mediated phosphorylation of CREB 1 at Ser-133 (1-3). Ser-133 phosphorylation, in turn, is thought to potentiate CREB transcriptional activity via recruitment of the coactivator CREB-binding protein (CBP). Additional effects of cAMP in enhancing CREB DNA binding activity have been noted; genomic footprinting studies on the tyrosine aminotransferase (4) and corticotropin-releasing factor (5) genes suggest, for example, that CREB binding to these promoters is increased following stimulation with a cAMP agonist. Moreover, structural studies indicate that CREB DNA binding activity may be modulated by cellular levels of divalent cations (6) . By contrast, chromatin immunoprecipitation studies have revealed that CREB binding to promoters is largely unaffected by extracellular signals (7) .
Recent imaging studies support the notion that DNA-binding proteins remain bound to their regulatory sites on chromatin only for a limited time before they dissociate again (8) . Indeed, estrogen and glucocorticoid receptors are thought to activate transcription via a hit-and-run model in which transient binding of these proteins to the promoter is sufficient to recruit the transcriptional apparatus.
To examine the dynamics of CREB binding to chromatin in vivo, we have employed fluorescence recovery after photobleaching (FRAP) analysis. In this method, confocal laser microscopy is used to bleach a small area within the nucleus of a live cell expressing a fluorescently tagged protein. By measuring the recovery time required for fluorescence within the bleached area to return to the base line, the residence time of a candidate protein on chromatin or other nuclear compartments can be evaluated. Using this approach, we have characterized relevant regions in CREB that stabilize its residence time in the nucleus, and we have measured the effects of cAMP as well as Ser-133 phosphorylation on the kinetics of CREB binding. The results provide additional insight into the mechanisms by which CREB regulates cellular gene expression.
EXPERIMENTAL PROCEDURES
Cell Culture and FRAP/FLIP Analysis-PC12 cells were maintained in Dulbecco's modified Eagle's medium with 10% horse serum, 5% fetal bovine serum, and antibiotics; NIH3T3 and HEK293T cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum and antibiotics. For FRAP and fluorescence loss in photobleaching (FLIP) analyses, 20,000 cells were plated into each chamber of an eight-chamber LabTek chambered coverslip (Nunc) and transfected with 0.4 g of DNA and 0.625 l of Lipofectamine 2000 (Invitrogen). PC12 cells were used for all experiments unless indicated otherwise. 24 -36 h after transfection, CO 2 -independent medium (Invitrogen) containing 10% horse serum and 5% fetal bovine serum was added, and cells were imaged on a Leica SP2 inverted scanning confocal microscope according to published protocols (10) . For FRAP analysis one prebleach image (three averaged frames) at 2% laser power was acquired, and a point bleach impulse of 500 ms with 100% laser power was applied. 20 post-bleach images were obtained at maximum speed, followed by 11 images at 10-s intervals and six images in 30-s intervals for a total time of 300 s. Intensities of the bleached area and the entire nucleus of background subtracted images were measured by Leica TCS software. The intensities in the bleached area were divided by total nuclear fluorescence, and the ratio in the prebleach image was set to 100%. The recovery kinetics of the bleached area shown are averages of at least 20 cells from at least two independent experiments. Residence times were determined from the recovery graphs as the time point when recovery was complete. Half-recovery times were determined from the recovery graphs as the time point when half of the intensity loss in the bleached area of the first post-bleach image was recovered. For proteins where recovery was almost complete before the first post-bleach image could be acquired, the average post-bleach intensity of CREB (30%) was used instead. Residence and half-recovery times for all constructs are summarized in supplementary Table I (available in the on-line version of this article). To determine the effects of a cAMP agonist on CREB residence time, cells were stimulated with 1 mM dibutyryl-cAMP (Sigma), incubated for 30 min, and analyzed as described above. For FLIP analysis, images (three averaged frames) were acquired at 45-s intervals, and a point bleach impulse of 500 ms was applied after each image until nuclear fluorescence was indistinguishable from background levels. The total nuclear fluorescence in the prebleach image was set to 100%, and results from at least 10 cells were averaged. To prevent potential artifacts from CREB overexpression, analysis was limited to cells that expressed the lowest amounts of a yellow fluorescent protein (YFP) fusion protein sufficient for a significant signal over background.
Plasmids-CREB fragments were PCR-amplified with Pfu polymerase (Stratagene) from published plasmids (12) , and inducible cAMP early repressor isoforms were amplified from reverse-transcribed PC12 cell total RNA. Amplified fragments were inserted into the XmaI/ BamHI sites of pYF-C2 C-terminal to YFP. Site-directed mutagenesis was performed with QuikChange (Stratagene) using Pfu polymerase. pCMX-YFP-mCBP-HA was a kind gift from R. Evans. YFP-TAF II 4 was generated by cutting an EcoRI/AflII fragment from pXJ40-TAF II 135 (kind gift from I. Davidson), blunting the AflII site with Klenow, and ligation into the EcoRI/SmaI sites of EYFP-C1 (Clontech). YFP-TAF II 1 was generated by ligating a BamHI/SpeI fragment from pHAXh250KTAF (provided by E. Wang) into the BglII/XbaI sites of EYFP-C1. Histone 2B-YFP was a kind gift from G. Wahl. To generate expression vectors for FLAG or Gal4 fusion proteins, YFP was released from the plasmids used for FRAP by AgeI/BglII digestion and replaced by a synthetic FLAG-linker or PCR-amplified Gal4-DBD (aa 1-147). Mutations and deletions in expression plasmids for CREB with a N-terminal triple HA tag (11) were generated by site-directed mutagenesis or by replacing BspEI/PpuMI fragments with deletion-containing fragments from published plasmids (12) . All plasmids were verified by sequencing.
Western Blotting-HEK293T or NIH3T3 cells were plated in 6-well plates, transfected with the indicated plasmids, and lysed in SDS-urea buffer. After separation on a polyacrylamide gel and transfer to nitrocellulose membrane, the blots were probed with rabbit polyclonal antiserum 5322 raised against a serine 133-phosphorylated CREB peptide (aa 128 -141), rabbit polyclonal antiserum 244 raised against CREB (aa 125-150), a FLAG-M1 antibody (Sigma) against a FLAG epitope, or a rabbit polyclonal antiserum raised against the green fluorescent protein (Santa Cruz Biotechnology). After incubation with a horseradish peroxidase-coupled secondary antibody, signals were detected by chemiluminescence (Western Lightning, PerkinElmer Life Sciences) and exposure to x-ray film.
Reporter Assays-HEK293T cells were plated in 24-well plates and transfected in triplicate with 25 ng of RSV-␤Gal, 25 ng of 5xGal4-luciferase reporter (pFR-Luc) or 50 ng of Evx1-luciferase reporter (13) , 100 ng of expression plasmid for Gal4-Q2 or YFP-fusion proteins, and 2 l of Lipofectamine 2000 (Invitrogen). 30 h after transfection, cells were stimulated with 10 M forskolin (Sigma) or Me 2 SO for 6 h, and luciferase activity was measured in cell extracts and normalized to ␤-galactosidase activity.
Electrophoretic Mobility Shift Assay-Nuclear extracts from HEK293T cells transfected with YFP fusion proteins were prepared by hypotonic lysis and douncing followed by high salt extraction in a buffer containing 20 mM HEPES, pH 7.9, 500 mM NaCl, and 25% glycerol. Binding reactions with 5 nM 32 P-labeled CRE oligonucleotide (Promega) were performed for 15 min at room temperature in a buffer containing 25 mM Tris-Cl, pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM MgCl, 0.5 mM dithiothreitol, 0.1 mg/ml bovine serum albumin, and poly(dI-dC). Where indicated, competition reactions with 10-and 100-fold excess of unlabeled double-stranded CRE oligonucleotide were performed. The samples were separated on a nondenaturing 5% polyacrylamide and 0.5ϫ Tris borate-EDTA gel containing 10% glycerol and autoradiographed according to standard protocols.
Coimmunoprecipitation-PC12 cells were transfected with FLAGtagged TAF II 4 and HA-tagged CREB using Lipofectamine 2000. Coimmunoprecipitation was performed as described (11) using FLAG-M1 beads (Sigma) for immunoprecipitation and horseradish peroxidasecoupled anti-HA antibody (Santa Cruz) for detection.
Chromatin Immunoprecipitation (ChIP)-ChIP on HEK293T cells transfected with expression vectors for FLAG-tagged proteins were performed as described (13) using FLAG-M1 beads (Sigma) or rabbit polyclonal antiserum 244 raised against CREB for immunoprecipitation followed by semi-quantitative PCR of the NR4A2 promoter for detection.
RESULTS
To evaluate CREB binding to chromatin, we performed FRAP studies using a full-length CREB polypeptide fused to YFP. Following transfection into PC12 pheochromocytoma cells, the YFP-CREB polypeptide was expressed and phosphorylated at comparable levels to endogenous CREB in response to cAMP agonist (not shown). YFP-CREB fluorescence emission was reduced by 70% following a bleach impulse and recovered to pre-bleach levels after 100 s (Fig. 1, a and c) . Similar results were obtained in NIH 3T3 cells, indicating that this behavior is not cell type-restricted (data not shown).
The ability of YFP-CREB fluorescence to recover completely in the bleached area indicates that the entire cellular CREB pool is in continuous exchange with binding sites on chromatin. Supporting this notion, FLIP analysis revealed that the entire pool of YFP-CREB could be bleached by repetitive exposure of a small area of the nucleus (Fig. 1b) . These results indicate that all YFP-CREB molecules enter the bleached area during the experiment, thus arguing against a permanently bound or immobile CREB fraction in the nucleus.
To test whether the long recovery time of CREB as compared with that of other transcription factors (8, 25) reflects stable binding to chromatin, we generated FRAP profiles on mutant CREB polypeptides that are deficient in either DNA binding (Fig. 1a , KCREB (R301L)) (14) or dimerization (Fig. 1a , L2/3V (L318V/L325V)) (15) . Relative to the wild-type protein, both mutant CREB polypeptides displayed much shorter recovery times in PC12 cells, on a par with YFP alone, indicating that the recovery time for CREB provides a reliable estimate of its residence time on chromatin (Fig. 1a) . Based on these results, the vast majority of cellular CREB would appear to be chromatin-bound at any given time point; compared with the DNA binding-defective R301L and L318V/L325V mutants, the wildtype CREB protein showed minimal instantaneous recovery after photobleaching.
CREB binds to DNA via a conserved basic region/leucine zipper (bZIP) DNA binding and dimerization domain (1-3). Based on its importance for CREB binding to DNA, we tested whether the bZIP (aa 283-341) alone would display comparable behavior to the wild-type CREB protein in FRAP assays. Unexpectedly, the YFP-bZIP polypeptide showed much faster recovery times (Fig. 1, c and d) ; similar results were obtained with the inducible cAMP early repressor Icer Ia and Icer Ib proteins (16) , which encode the highly related bZIP domain of the CRE modulator (CREM). Taken together, these results argue for the involvement of additional domains in CREB that promote residence time on chromatin.
In addition to the C-terminal bZIP domain, CREB contains a central kinase-inducible domain (KID) (aa 100 -160) flanked by glutamine rich domains referred to as Q1 (aa 1-100) and Q2 (aa 160 -283) (Fig. 2a) (1) . Deletion of Q1 (Fig. 2b, CREB⌬Q1 ) did not dramatically shorten residence time, but removal of the Q2 (CREB⌬Q2) domain reduced residence time to the level of the bZIP alone. Deleting KID in addition to Q1 (Q2bZIP) actually prolonged residence time, indicating that Q2 and the bZIP regions are both necessary and sufficient for stable binding of CREB to chromatin. The ability of Q2 to promote stable chromatin binding was not strictly correlated with glutamine content or hydrophobicity, as fusion of Q1 to the bZIP had no effect in this regard (Fig. 2b, Q1bZIP versus bZIP) .
Q2 has been shown to stimulate target gene expression via an association with hTAF II 4 (also known as hTAF II 135), a component of TF II D (17) (18) (19) (20) . Q2 binds to hTAF II 4 in part via a short interaction motif (LQTL; aa 204 -207) that is conserved in the glutamine-rich B domain of SP1 (SP1B) (9, 18) . Deletion of sequences encoding the hTAF II 4 interaction motif (Fig. 2c,  ⌬204 -213) , however, had only marginal effects on the residence time of CREB and Q2bZIP by FRAP assay, arguing against a significant role for this interaction in stabilizing CREB binding to chromatin. By contrast, deletion of residues amino-terminal to the hTAF II 4 interaction motif in Q2 (CREB⌬162-179 and Q2bZIP⌬161-185) had far more significant effects, reducing residence time to levels comparable with that of the CREB bZIP domain alone (supplemental Table I and Fig. 2c ; compare with Fig. 2b bZIP) . Arguing against large conformational changes in explaining these effects, we observed similar results in alanine scanning mutagenesis studies; substitution of aa 182-185 (YIAI) with AAAA, for example, shortened residence time in the context of Q2bZIP as well as full-length CREB polypeptides (Fig. 2d, YIAI) . But substitutions in other putative TAF II 4 interaction motifs (GAIQL-RAAQA (aa 189 -193) and LQTL-AQAA (aa 204 -207)) (17) had no effect in this regard.
The ability of certain glutamine-rich domains to aggregate nonspecifically, particularly in polyglutamine repeat disorders such as Huntington disease (21) , prompted us to examine whether the effect of Q2 in prolonging CREB residence time reflects an underlying propensity of this domain for self-aggregation. In FRAP assays of PC12 cells, a YFP-Q2 polypeptide behaved much like free YFP with almost instantaneous and complete recovery, even in cells expressing the YFP-Q2 polypeptide at very high levels (supplemental Table I ). Indeed, a mutant Q2bZIP containing an R301L substitution that disrupts the CREB DNA binding domain also showed short recovery times as compared with those of the wild-type Q2-bZIP polypeptide (supplemental Table I ), supporting the notion that Q2 prolongs CREB residence time in concert with the bZIP domain rather than via self-aggregation.
The importance of Q2 in stabilizing CREB binding to chromatin by FRAP assay prompted us to examine the effects of this region on CREB occupancy over an endogenous promoter by ChIP assay. We employed the NR4A2 gene for these studies, based on the presence of two consensus CRE sites that bind to CREB in vivo and mediate cAMP-dependent induction of this gene in a variety of cell contexts (7). Although FLAG-tagged CREB and CREB⌬Q2 proteins were comparably expressed in HEK293T cells by Western blot analysis (data not shown), binding of CREB⌬Q2 polypeptide to the NR4A2 promoter was reduced ϳ5-fold relative to wild-type CREB protein (Fig. 2e) . In keeping with FRAP results, the YIAI 3 AAAA (aa 182-185) CREB protein showed intermediate levels of binding to the NR4A2 promoter, demonstrating that differences in residence times between wild-type and mutant CREB proteins are indeed reflected at the level of promoter binding.
To evaluate whether CREB residence time is critical for target gene induction, we compared the activities of wild-type and mutant polypeptides in the context of either a GAL4-Q2 protein containing the Q2 domain fused to the GAL4 DNA binding domain (aa 1-147) (Fig. 3a) or in the context of the full-length CREB protein (Fig. 3b ) in HEK293T cells. In both settings, CREB polypeptides containing mutations in Q2 that reduced residence time by FRAP assay showed lower activity by reporter assay under basal conditions as well as in response to cAMP agonist (Fig. 3, a and b) . Consistent with its reduced residence time relative to the wild-type protein, for example, CREB⌬Q2 was nearly 10-fold less active compared with the wild-type protein. Conversely, one alanine-scanning mutant (TSSG) with increased residence time by FRAP assay (Fig. 2d) exhibited higher transcriptional activity, at least in the context of full-length CREB (Fig. 3b) .
We observed a strong linear correlation between residence time and transcriptional activity for CREB polypeptides, either in the context of Gal-Q2 or the full-length protein by regression analysis (Fig. 3c: r ϭ 0.92, 0 .88, and 0.93 for Gal4-Q2, CREB, and CREB following cAMP stimulation, respectively). Arguing against the potential effects of these mutations on protein kinase A substrate recognition, the profiles for Ser-133 phosphorylation in response to the cAMP agonist were similar between the mutant and wild-type CREB proteins (Fig. 3d, and Table I . e, ChIP assay of the NR4A2 promoter in HEK293T cells transfected with FLAG-tagged CREB (CREB), FLAG-tagged YIAI 3 AAAA CREB (YIAI), FLAG-tagged CREB Q2 domain deletion mutant (⌬Q2), or empty FLAG vector (mock). PCR amplification of products from immunoprecipitates prepared with anti-FLAG (␣Flag) or anti-CREB (␣CREB) antiserum is shown.
data not shown). By contrast with hit-and-run models of transcriptional activation for other nuclear factors, these results support the notion that continuous binding of CREB to the promoter is critical for target gene activation in response to cAMP stimulus.
Whether and to what degree cAMP alters binding of CREB to target promoter sites is controversial (1). Exposure of PC12 cells to a cAMP agonist caused no discernible change in the recovery kinetics of YFP-CREB however, and mutation of the Ser-133 phospho-acceptor site to Ala was similarly ineffective in altering CREB dynamics (Fig. 4a) , arguing against a role for either CREB phosphorylation or CBP/p300 recruitment in stabilizing CREB binding to its target sites. Further supporting this notion, the residence times for CBP and other putative CREB co-activators such as TAF II 4 and TAF II 1 (22) were actually shorter than that for CREB (Fig. 4b) .
The importance of TAF II 4 recruitment for CREB activation via the Q2 domain (17, 18, 23) prompted us to examine further whether mutations in Q2 that reduce CREB residence time also inhibit the TAF II 4 interaction. Wild-type CREB was found to associate with TAF II 4 in PC12 cells by a Western blot assay of FLAG-tagged hTAF II 4 immunoprecipitates prepared from PC12 cells (Fig. 4c) . Deletion of the Q2 domain (CREB ⌬Q2) completely disrupted CREB-hTAF II 4 complex formation (18) . By contrast, a short residence time mutant YIAI 3 AAAA (aa 182-185) CREB polypeptide showed no reduction in hTAF II 4 binding relative to the wild-type protein by co-immunoprecipitation assay, arguing against a significant role for this interaction in stabilizing CREB binding to chromatin.
We considered the possibility that mutagenesis or deletion of the Q2 domain may affect the intrinsic DNA binding activity of CREB, perhaps by altering its conformation. To test this notion, we performed electrophoretic mobility shift assays using a 32 P-labeled double-stranded CRE oligonucleotide on nuclear extracts of HEK293T cells transfected with CREB expression vectors. Notably, CREB polypeptides with either long (CREB, Q2bZIP) or short (Q2bZIP⌬161-185, Q2bZIP YIAI) residence times in vivo showed comparable CRE binding affinities by gel mobility shift assay in vitro. These results indicate that Q2 selectively stabilizes promoter occupancy in the context of a chromatin template (Fig. 4d) .
To determine whether the ability of the Q2 domain to prolong residence time and increase chromatin binding is shared by other glutamine-rich activators, we performed domain ex- change experiments with the glutamine rich B trans-activation domain of SP1, SP1B (9, 24) . When fused to the CREB bZIP, SP1B was actually more potent than Q2 in prolonging residence time (Fig. 5a , Sp1BbZIP versus bZIP; compare with Fig.  2b , Q2bZIP; see supplemental Table I ). Fusion of SP1B to the c-Jun DNA binding domain (Sp1BJunDBD versus c-Jun) also prolonged its residence time by FRAP assay, suggesting a more general effect of this region on chromatin binding (Fig. 5a ).
In keeping with these effects on residence time, the SP1B domain also enhanced CREB bZIP promoter occupancy; in ChIP studies of HEK293T cells, the Sp1B-bZIP fusion protein exhibited 4-fold higher binding to the NR4A2 promoter relative to wild-type CREB, despite similar levels of protein expression ( Fig.  5b ; data not shown). Consistent with this profile, fusion of SP1B to a CREB mutant polypeptide lacking both Q1 and Q2 domains ( Fig. 5c ; compare KIDbZIP and KIDSp1BbZIP) enhanced the activity of a co-transfected CRE luciferase reporter plasmid 3-fold in HEK293T cells. Taken together, these studies demonstrate that stable binding of CREB to a promoter is in part guided by Q2 and bZIP domains and that such effects on promoter binding are transmitted at the level of cellular gene expression.
DISCUSSION
The concept of residence time as a relevant parameter for transcriptional activation is relatively new. Recent studies using FRAP analysis indicate that transcriptional activators cycle rapidly on and off chromatin; steroid hormone receptors (8, 25) appear to turn over with surprisingly rapid kinetics, for example, suggesting that certain activators leave and return to the promoter many times during the course of transcriptional activation. Other transcription factors such as Jun, the CCAAT/enhancer-binding protein, and Myc, however, show longer residence times of 5-10 s (10). In many cases, promoter engagement of the polymerase appears to be inefficient, with incomplete and abortive assembly being the rule rather than the exception (26) . Treatment with cAMP did not alter CREB residence time, arguing against a significant role for Ser-133 phosphorylation or changes in divalent cations (6) in modulating CREB binding. However, our results do not rule out genespecific effects in which CREB may be recruited to certain promoters via interactions with other regulatory partners.
We have described a novel activity in the glutamine-rich Q2 domain of the transcription factor CREB that increases resi- FIG. 4 . CREB residence time is not modulated by cAMP stimulation or CREB coactivators. a, fluorescence recovery curves of wild-type and S133A mutant YFP-CREB proteins in control and 1 mM dibutyryl-cAMP-stimulated PC12 cells. b, fluorescence recovery curves for CREB co-activators CBP, TAF II 4, and TAF II 1 fused to YFP. c, co-immunoprecipitation (IP) of HA-tagged CREB proteins with FLAG-tagged TAF II 4 in PC12 cells. WB, Western blot. d, electrophoretic mobility shift assay using a 32 P-labeled, double-stranded CRE oligonucleotide plus HEK293T extracts expressing wild-type and mutant YFP-CREB proteins. The addition of an unlabeled CRE competitor (comp; 10 and 100-fold excess) to binding reactions is indicated. dence time and transcriptional activity. The Q2 domain of CREB is a member of the family of glutamine-rich activation domains that are defined rather loosely by their high glutamine content and intrinsic transcriptional activity. With the exception of a four amino acid motif (W/L)QTL that appears to mediate an interaction with hTAF II 4, these activators lack significant sequence homology and are only incompletely understood on a structural and mechanistic level. The Q2-hTAF II 4 interaction is unlikely to explain the effect of Q2 on CREB by FRAP assay; mutations in Q2 that reduce the interaction with hTAF II 4, did not shorten residence time. Conversely, mutations having a strong effect on recovery kinetics did not alter the interaction with hTAF II 4.
The ability of the SP1B domain to substitute for Q2 suggests a more general role for glutamine-rich activators in stabilizing the binding of transcriptional regulators like CREB to chromatin. Although Q2 and SP1B were found to enhance CREB binding when tested as fusion products, these domains may function similarly in trans, for example when SP1 and CREB binding sites are located on the same promoters. Indeed, SP1 and CREB have been found to act cooperatively on target gene expression (27, 28) . Further supporting this notion, SP1 has been shown to facilitate occupancy of c-Jun on certain promoters (29) . Future studies may reveal the extent to which glutamine-rich activators stabilize the binding of other nuclear factors to relevant target genes.
